ASSOCIATION DEEP VEINOUS THROMBOSIS WITH PULMONARY TUBERCULOSIS

Authors

  • Leila El Fekih Service de pneumologie Ibn Nafiss. Hôpital Abderrhmane MAMI de L'ARIANA
  • Imen Oueslati Service de pneumologie Ibn Nafiss. Hôpital Abderrhmane MAMI de L'ARIANA
  • Hela Hassene Service de pneumologie Ibn Nafiss. Hôpital Abderrhmane MAMI de L'ARIANA
  • Souraya Fenniche Service de pneumologie Ibn Nafiss. Hôpital Abderrhmane MAMI de L'ARIANA
  • Dalenda Belhabib Service de pneumologie Ibn Nafiss. Hôpital Abderrhmane MAMI de L'ARIANA
  • Mohamed Lamine Megdiche Service de pneumologie Ibn Nafiss. Hôpital Abderrhmane MAMI de L'ARIANA

Keywords:

Tuberculosis, thrombosis, anticoagulant, treatment

Abstract

Background : Pulmonary tuberculosis has been reported as a risk factor for deep venous thrombosis. Aim: In the present study we reported, physiopathological,
epidemiological, clinical and therapeutic features of the association of deep venous thrombosis and pulmonary tuberculosis.
Methods: This is a retrospective study done in our department between January 2000 and December 2007 .It is about 14 cases of confirmed pulmonary tuberculosis associated with deep venous thrombosis.
Results: It is about 14 men. The mean age was 40 years old. Pulmonary tuberculosis was confirmed by the presence of acidoalcoolo- resistant bacillus on the sputum at direct exam in 12 cases (81, 8%) and in the bronchial aspiration in 2 cases (18%). Phlebitis occurred within a mean of 20 days after the diagnosis of tuberculosis. It was confirmed by doppler deep venous ultrasound of inferior members. All patients received anti-tuberculosis drugs in association with anticoagulant treatment. Etiologic investigations showed positive anti-phospholipids antibodies in one case, and decrease in C and S proteins for 2 patients in which phlebitis was complicated by arterial pulmonary embolism. We had difficulties for controlling prothrombin level in 4 cases and we must prescribe low molecular weight heparin for 6 months in one case.
Conclusion: A lot of attention should be done, in the follow up of pulmonary tuberculosis especially in severe presentation; because of the deep venous thrombosis’s risk occurrence. Prophylactic anticoagulant treatment should be done in some cases, when the risk is higher.

Downloads

Download data is not yet available.

References

Irene M, Mackman N, Kriett J. Prothrombotic activation of pulmonary arterial endothelial cells in patient with tuberculosis. Hum Pathol 1996; 27:423-27.

Zahn W, Pierce T. Venous thrombosis and pulmonary embolism in Tuberculosis. AM J Med 1980; 8: 716-728.

Robson SC, Withe NW, Aronson J. Acute phase response and the hypercoagulable state in pulmonary tuberculosis.Br J Haematol 1996;4: 943-9.

Ortega S, Viscaino J, Aquirre I. Tuberculosis as risk factor for venous thrombosis. An Med Interna 1993; 8: 398-400.

Turken O, Kunter E, Sezer M. Hemostatic changes in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2002; 10: 927-32.

Naithani R, Aqrawal N, Choudhary VP. Deep venous thrombosis associated with tuberculosis. Blood coagul Fibrinolysis 2007;4: 377-80.

Downloads